(PCX) PCC Exol - Ratings and Ratios
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLPCCEX00010
PCX: Surfactants, Anionic, Nonionic
PCC Exol S.A. is a leading manufacturer and global supplier of surfactants, operating primarily in Poland and extending its reach internationally. The company specializes in producing anionic and nonionic surfactants, which are essential components in various industrial applications. Its product portfolio serves a diverse range of sectors, including household and industrial chemicals, textiles, plastics, industrial cleaning, metalworking, and other specialized industries. Headquartered in Brzeg Dolny, Poland, PCC Exol S.A. is a key subsidiary of PCC SE, a prominent player in the chemical industry. The company is committed to innovation and sustainability, investing in research and development to enhance its product offerings and meet evolving market demands. PCC Exol S.A. also prioritizes environmental responsibility, ensuring its manufacturing processes adhere to stringent environmental standards. For more information, visit their official website at https://www.pcc-exol.eu.
Ticker Symbol: PCX
Exchange: WAR
Type: Common Stock
Country Origin: Poland
GICS Sub Industry: Specialty Chemicals
Based on the provided
Over the next three months, PCC Exol S.A. (WAR:PCX) is expected to experience moderate price stabilization. The stocks short-term moving averages (SMA 20: 2.39, SMA 50: 2.32) suggest a slight upward trend, while the long-term SMA 200 (2.55) indicates potential resistance. The low Average True Range (ATR: 0.05) signals minimal volatility, implying that price fluctuations will likely remain constrained. From a fundamental perspective, the companys P/S ratio of 0.46 and P/B ratio of 0.92 suggest undervaluation relative to its peers, which could attract investors seeking opportunities in the specialty chemicals sector. However, the absence of a forward P/E ratio and a modest RoE of 6.01% may temper near-term growth expectations. Overall, the stock is anticipated to trade within a narrow range, with potential for slight upside driven by improving industry demand and the companys strategic initiatives.
Additional Sources for PCX Stock
PCX Stock Overview
| Market Cap in USD | 106m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Specialty Chemicals |
| IPO / Inception |
PCX Stock Ratings
| Growth 5y | -15.2% |
| Fundamental | 40.7% |
| Dividend | 45.8% |
| Rel. Strength | -6.52 |
| Analysts | - |
| Fair Price Momentum | 1.98 PLN |
| Fair Price DCF | 3.13 PLN |
PCX Dividends
| Dividend Yield 12m | 2.94% |
| Yield on Cost 5y | 4.07% |
| Annual Growth 5y | 6.96% |
| Payout Consistency | 81.7% |
PCX Growth Ratios
| Growth Correlation 3m | 24.5% |
| Growth Correlation 12m | -88.8% |
| Growth Correlation 5y | -14.3% |
| CAGR 5y | 4.85% |
| CAGR/Max DD 5y | 0.06 |
| Sharpe Ratio 12m | -2.66 |
| Alpha | -17.96 |
| Beta | 1.444 |
| Volatility | 23.66% |
| Current Volume | 50.6k |
| Average Volume 20d | 7.9k |
As of April 09, 2025, the stock is trading at PLN 2.18 with a total of 50,637 shares traded.
Over the past week, the price has changed by -6.44%, over one month by -7.63%, over three months by -7.43% and over the past year by -21.35%.
Partly, yes. Based on ValueRay Fundamental Analyses, PCC Exol (WAR:PCX) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.68 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PCX as of April 2025 is 1.98. This means that PCX is currently overvalued and has a potential downside of -9.17%.
PCC Exol has no consensus analysts rating.
According to ValueRays Forecast Model, PCX PCC Exol will be worth about 2.2 in April 2026. The stock is currently trading at 2.18. This means that the stock has a potential downside of -0.46%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2.2 | -0.5% |